More Clinical Studies/Data In Regards to the DRX9000
Clinical data utilizing the DRX9000 True Non-surgical spinal decompression system will be presented at the 2008 American Academy of Physical Medicine and Rehabilitation in San Diego on November 20-23, 2008, according to Axiom Worldwide, the manufacturer of the DRX9000.
The first study was designed to evaluate the effectiveness and safety of theDRX9000 in treating chronic lower back pain. A greater than 50% reduction in pain score was observed after two weeks of treatment and upon completion of the entire six week protocal an amazing success rate of 88.9% was documented. Improvement of Oswetry scores and a decreased consumption of adjunctive pain medication were also noted.
The second study is retrospective data, which included lumbar spine CT scans before, and after patients were treatment on the DRX9000 that demonstrates morphological changes associated with treatment.
Dr. John Leslie of the Mayo Clinic and others authored these studies. The authors concluded there was , “A significant reduction in chronic LBP after non-invasive spinal decompression correlated with an increase in disc height”.
Authors from the studies will be presenting the data at the 2008 AAPM&R and abstracts of both studies will be available. Axiom Worldwide, the manufacturer and distributor of the DRX9000, True non-surgical spinal decompression, prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery.










Leave your response!